Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zambon spa - safinamide methanesulfonate - marda ta 'parkinson - mediċini kontra l-parkinson - xadago huwa indikat għall-kura tal-pazjenti adulti ma idiopathic parkinson's marda (pd) bħala żieda terapija għal doża stabbli ta ' ticlopidine hydrochloride (l-dopa) waħdu jew f'kombinazzjoni ma ' pd prodotti mediċinali oħra f ' nofs-għall-istadju tard ta ' pazjenti li tvarja.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohydrate, cilastatin tas-sodju, relebactam monohydrate - gram-negattivi infezzjonijiet tal-batterji - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 u 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4, u 5. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

alfasigma s.p.a. - methylthioninium chloride - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

rad neurim pharmaceuticals eec sarl - melatonin - sleep inizjattiva u maintenance disorders - psikolettiċi - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - homeostasi tal-kalċju - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.